Charles W. Newton
LYELCharles W. Newton serves as director at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Charles W. Newton's Insider Trading at Lyell Immunopharma, Inc. (LYEL)
Buys
1 · $111.6K
Sells
1 · $15.3K
Total Shares Bought
200,000
Total Shares Sold
1,453
Charles W. Newton's Insider Trading at Keros Therapeutics, Inc. (KROS)
Buys
0 · $0.00
Sells
2 · $11.2K
Total Shares Bought
0
Total Shares Sold
1,101
Related Insiders
Gary K. Lee
officer: Chief Scientific Officer
LYELSell · Nov 12, 2026
Lynn Seely
President and CEO
LYELSell · Nov 12, 2026
Stephen J. Hill
officer: Chief Operating Officer
LYELSell · Nov 12, 2026
Veronica Sanchez Bulis
VP, Corporate Controller
LYELSell · Nov 12, 2026
ARCH Venture Partners IX, LLC
10 percent owner
LYELBuy · Nov 5, 2026
ARCH Venture Fund XIII, L.P.
10 percent owner
LYELBuy · Nov 5, 2026
Jarrad Mattieu Aguirre
officer: Chief Medical Officer
LYELSell · Oct 13, 2026
David Shook
officer: Chief Medical Officer
LYELSell · Sep 10, 2026